Kintor Pharmaceutical, a Chinese drug developer backed by the likes of HighLight Capital and Shenzhen Green Pine Capital Partners, posted a 7% gain on debut following a HK$1.86 billion ($240 million) Hong Kong IPO.
The company sold 92.3 million shares for HK$20.15 apiece, with the portion of the offering allocated to Hong Kong-based investors more than 550 times oversubscribed, according to a filing. A further 13.9...
Manila-based private equity firm Navegar has closed its second Philippines fund with $197 million in commitments. The initial target was $150 million.
Singapore-headquartered investment firm Blue Ashva Capital has secured a first close of INR4.5 billion ($60 million) for an India-domiciled fund that will invest in small and medium-sized enterprises (SMEs) and start-ups.
Investcorp has led a $56 million Series C round for Indian managed co-living accommodation platform operator Zolo.
Energy giant BP has agreed to invest $70 million in Green Growth Equity Fund (GGEF), a PE vehicle co-managed by Everstone Group that invests in sustainable infrastructure projects in India.